Tyra Biosciences (TYRA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Tyra Biosciences (TYRA) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.05 of bullish evidence against -0.24 bearish.

Tyra Biosciences last closed at $20.24, -3.30% on the session.

Against the IVW growth benchmark the position is -3.91% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

Tyra Biosciences has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Tyra Biosciences in the 19th percentile on return on equity, where 100 is best.

Tyra Biosciences is classified under Health Care / Biotechnology, with a market capitalisation of $1.44B.

StockMap tracks Tyra Biosciences as the 112th largest of the 365 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 190 Moderate Underperform, 164 Neutral and 11 Strong Underperform.

On that composite Tyra Biosciences ranks 192nd of 365 in the group, against a group median of -0.21.